Mental Health and Wellbeing Market Research for Industry Stakeholders

Deliberate, evidence-driven market research is essential to design, scale and sustain mental health and wellbeing products, services and policies. At Research Bureau, we deliver actionable insights that help investors, product teams, payers, employers, providers and policymakers make confident decisions—without offering clinical treatment or medical advice. Share your project details for a bespoke quote, or contact us via the form, WhatsApp icon, or email: [email protected].

Why specialised mental health & wellbeing research matters now

Mental health and wellbeing markets are shaped by cultural norms, regulatory shifts, digital innovation and evolving care pathways. Generic market research misses the nuance of lived experience, stigma, access barriers, and longitudinal outcomes that define value in this field. High-quality research reduces risk—informing product-market fit, pricing, adoption, and long-term sustainability.

Stakeholders who invest in rigorous, ethically conducted market research realize benefits such as:

Faster adoption through evidence-based positioning and messaging.
Higher retention by aligning features to user needs and contexts.
Smarter allocation of capital by focusing on validated demand and realistic forecasts.
Regulatory and payer readiness by mapping evidence requirements and reimbursement pathways.

Who this research serves

We design tailored research programs for a wide range of stakeholders, including:

Employers and HR/Wellbeing teams seeking to select or optimise employee mental health programs.
Digital mental health product teams validating features, pricing and retention strategies.
Investors and corporate development teams performing due diligence and market sizing.
Healthcare payers and insurers assessing coverage models and cost implications.
Nonprofits and public sector bodies evaluating program impact and scaling strategies.
Providers and clinic networks exploring service design and referral pathways.

We do not provide medical care; instead, we provide market intelligence that supports non-clinical decision-making.

Core objectives we solve

Every project starts by aligning on the primary business objective. Typical objectives include:

Market sizing and growth forecasting to inform investment decisions.
Uncovering unmet needs and segmentation for product design.
Concept testing and pricing to optimise launch strategy.
Pathway mapping for employers, payers and providers.
Behavioral drivers analysis to increase uptake and retention.
Benchmarking and competitive intelligence for differentiation.

Research approaches — rigorous, mixed-methods design

We apply mixed-methods research to reconcile depth and breadth. Each program blends qualitative and quantitative approaches tailored to your objective, budget and timeline.

Qualitative approaches (when to use):

In-depth interviews with users, clinicians, HR leaders and payers to uncover motivations and barriers.
Focus groups to explore stigma, language, and messaging sensitivities across demographics.
Journey mapping workshops to visualise real-world touchpoints and friction.

Quantitative approaches (when to use):

Large-scale surveys for prevalence, willingness-to-pay and segmentation quotas.
Discrete choice experiments (DCEs) and conjoint analysis for pricing and feature trade-offs.
Longitudinal cohort studies and retention analytics to measure engagement trends.

We can include bespoke modules such as passive data collection (usage analytics), ecological momentary assessment (EMA) for symptom fluctuation research, and secondary data synthesis (claims, public health datasets) while observing strict de-identification standards.

Method comparison table

Research Method	Primary Use	Typical Sample Size	Strengths	Limitations
In-depth interviews	Explore motivations, barriers	20–60	Rich narrative detail; ideal for product design	Not statistically generalisable
Focus groups	Messaging and social norms	6–10 per group	Quick insights on language and stigma	Social desirability bias
Online surveys	Prevalence, segmentation, pricing	300–5,000+	Scalable, quantifiable	Requires careful sampling
Discrete Choice Experiments	Feature/value trade-offs	400–1,200	Powerful for pricing/product decisions	Design complexity
Longitudinal cohort	Retention, behavioural changes	200+	Measures change over time	Higher cost/time
Passive analytics	Real-world engagement	Entire user base	Objective usage data	Requires technical integration

Ethical safeguards and data governance

Ethics and participant safety are central. We never provide clinical treatment or suggest diagnostic steps; our work is strictly market research and behavioural analysis. Our approach includes:

Informed consent with plain-language explanations of purpose and data use.
De-identification and anonymisation of personally identifiable information.
Compliance with applicable data protection laws (e.g., POPIA, GDPR) and industry best practices.
Risk escalation pathways when research encounters acute distress: responders are trained to recommend professional support and provide emergency contacts, not to act as clinicians.
Institutional review board (IRB) or ethics committee coordination where required by funders or partners.

Sampling strategy and representation

Robust sampling avoids bias and overgeneralisation. We construct sampling strategies based on your objectives:

Quota sampling by demographics, severity, geography, or employment status for representative insights.
Oversampling of underrepresented groups to understand disparities in access and outcomes.
Panel recruitment via validated third-party panels, clinical registry partners, employer cohorts, and community organisations.
Power calculations and margin-of-error modelling to determine required sample sizes for quantitative endpoints.

Deliverables — actionable outputs, not just PDFs

We emphasise deliverables that drive decisions. Standard outputs include:

Executive summary with clear recommendations and strategic options.
Detailed methodology appendix for reproducibility and stakeholder scrutiny.
Segment profiles and user personas with behavioural triggers and communication guidance.
Market sizing and 3–5 year forecasts with scenario analysis.
Product/feature prioritisation matrix and roadmap recommendations.
Pricing and reimbursement playbook tailored to your target customers.
Interactive dashboards (Power BI/Tableau) for on-demand slicing of survey data.
Workshop facilitation for roadmap alignment with stakeholders.

Deliverables vs Benefits

Deliverable	Business Benefit
Market sizing & forecasts	Investment and capacity planning
Segmentation & personas	Targeted product design and messaging
Pricing experiments & DCEs	Revenue and monetisation optimisation
Journey maps	Reduced friction and higher adoption
Benchmarks & competitive analysis	Clear differentiation & go-to-market strategy
Dashboards & data access	Faster decision cycles & stakeholder reporting

Designing research for different stakeholders

Research questions vary by stakeholder. Below are common use cases and our recommended approaches.

Employers and HR teams

Objectives: Select vendors, measure program ROI, increase uptake.
Methods: Employer surveys, employee anonymised wellbeing surveys, usage analytics, employer cost-benefit modelling.
Outputs: Vendor scorecards, engagement funnels, communications playbooks.

Digital mental health product teams

Objectives: Achieve product-market fit, improve retention, validate pricing.
Methods: User interviews, in-app analytics, A/B testing, DCEs.
Outputs: Feature prioritisation, churn drivers, pricing recommendations.

Payers and insurers

Objectives: Evaluate coverage models, cost-effectiveness, provider networks.
Methods: Claims data analysis, modelling of utilisation and cost offsets, stakeholder interviews with providers.
Outputs: Reimbursement submission-ready evidence summaries and economic impact projections.

Investors and M&A teams

Objectives: Market size, competitor landscape, customer acquisition cost (CAC) benchmarks.
Methods: Market mapping, due diligence interviews, unit economics modelling.
Outputs: Investment thesis alignment, risk matrix, go/no-go recommendations.

Public sector & NGOs

Objectives: Program evaluation, scale models, equity analysis.
Methods: Mixed-method evaluations, process evaluations, pre-post studies.
Outputs: Impact reports, scaling roadmaps, monitoring & evaluation (M&E) frameworks.

Product and service testing — from hypothesis to validated features

We structure product testing into three stages: discovery, validation, and optimisation.

Discovery (rapid, qualitative)

Identify unmet needs and core user problems through interviews and contextual inquiry.
Map emotional and functional jobs-to-be-done to guide ideation.

Validation (quantitative)

Test value propositions and willingness-to-pay with representative surveys and conjoint designs.
Use concept testing to refine messaging and target segments.

Optimisation (behavioural experiments)

A/B test onboarding flows, incentives and content to lift activation and retention.
Use cohort analytics and funnel diagnostics to quantify lift and ROI.

Pricing, monetisation and willingness-to-pay

Pricing in mental health markets depends on channel (B2B vs B2C), perceived value, and third-party reimbursement norms. Our pricing toolkit includes:

Conjoint analysis to estimate feature-level value.
Van Westendorp and Gabor-Granger techniques for price sensitivity.
Competitive pricing benchmark with positioning laddering.
Scenario modelling for subscription, per-user, per-member-per-month (PMPM) and outcome-based contracts.

We translate findings into defensible pricing strategies and sensitivity analyses to inform contract negotiations and commercial forecasts.

Measuring impact and ROI

For employers, payers and investors, impact translates into measurable business outcomes. We link behavioural and health-related metrics to business KPIs:

Engagement metrics: MAU/DAU, session length, completion of modules.
Clinical-adjacent outcomes: self-reported functioning and wellbeing measures (used for market research purposes only).
Economic outcomes: absenteeism reduction, productivity proxies, utilisation changes.
Financial ROI: cost offsets modelled against implementation costs and subscription fees.

We provide conservative, base and upside ROI scenarios based on empirical data and validated assumptions.

Regulatory & reimbursement landscape mapping

Mental health products increasingly intersect with reimbursement and regulatory scrutiny. We map:

Local and regional regulatory frameworks relevant to product claims and marketing.
Payer evidence expectations for reimbursement or preferred vendor status.
Data privacy and security requirements impacting integration with electronic health records or insurer systems.

Our regulatory mapping is advisory and based on publicly available frameworks; we do not provide legal advice.

Competitive intelligence & landscape analysis

Understand where to play and how to defend. Our competitive intelligence includes:

Feature and pricing comparisons across competitors.
Positioning and messaging audits with sentiment analysis.
Channel strategy audits: partnerships, direct-to-consumer, employer sales.
Differentiation opportunities grounded in customer needs and operational capabilities.

Analytics, modelling and forecasting

We provide robust quantitative analytics using industry-standard techniques:

Time-series forecasting for market growth scenarios.
Customer lifetime value (LTV) and CAC models for unit economics.
Multivariate regression to identify independent drivers of retention and engagement.
Survival analysis for churn and retention curves.

Interactive dashboards allow you to update assumptions and stress-test scenarios.

Data collection platforms and tools

We use proven platforms aligned to your needs:

Survey platforms: Qualtrics, SurveyMonkey, custom APIs for complex designs.
Analytics: Mixpanel, Amplitude, Google Analytics, server-side event tracking.
Qualitative tools: Dovetail, NVivo for coding and synthesis.
Visualisation: Power BI, Tableau, and bespoke dashboards for stakeholder reporting.

We can integrate with your existing tech stack or collect data independently, maintaining strict security practices.

Pricing and engagement models

We tailor engagements per scope. Typical engagement models:

Rapid discovery sprint: 4–6 weeks, targeted qual + small survey for quick validation.
Standard project: 8–12 weeks, mixed-methods, representative survey, deliverables package.
Longitudinal evaluation: 6–18 months, cohorts and ongoing analytics.
Retainer partnerships: Continuous research & insight support for product roadmaps and market surveillance.

Indicative price ranges (high-level):

Rapid sprint: from ZAR 85,000
Standard mixed-methods: ZAR 250,000–ZAR 650,000
Longitudinal evaluations: ZAR 450,000+
Prices vary by sample size, specialist panels, integrations and regulatory needs. Share project details for a tailored quote.

Typical timeline

A standard mixed-methods program often follows this cadence:

Week 1–2: Project scoping, protocol development and ethical screening.
Week 3–5: Qualitative fieldwork and initial analysis.
Week 6–8: Survey fieldwork and quantitative analysis.
Week 9–10: Synthesis, workshops and final reporting.

Timelines shorten for discovery sprints and extend for longitudinal or complex payer studies.

Example engagements — anonymised outcomes

Case study 1 — Digital mental health app (anonymised)

Objective: Improve onboarding and reduce early churn.
Approach: User interviews, funnel analysis, A/B testing of onboarding flows.
Outcome: Iterative changes increased Day-7 retention by a single-digit percentage point margin and clarified messaging that improved conversions from freemium to paid tiers.

Case study 2 — Employer wellbeing program selection (anonymised)

Objective: Select a third-party vendor aligned with workforce needs.
Approach: Employee wellbeing survey (n=1,200), vendor feature gap analysis, ROI modelling.
Outcome: Employer selected a vendor with a tailored pilot and predictive engagement model that supported phased rollout and measurement.

Case study 3 — Investor due diligence (anonymised)

Objective: Validate TAM and unit economics for a potential acquisition.
Approach: Market sizing, competitive landscape, customer interviews and CAC/LTV stress testing.
Outcome: Clear valuation levers identified and post-merger integration priorities recommended.

These are anonymised summaries to illustrate typical outputs; we can provide more detailed examples under NDA.

Common FAQs

What makes Research Bureau different?

We combine deep market research expertise with sector-specific nuance in mental health and wellbeing. Our approach emphasises ethical conduct, representative sampling and commercially actionable outputs.

Do you provide clinical assessments or therapy?

No. We do not provide medical or therapeutic services. Our role is to study markets, behaviours and systems—not to diagnose or treat individuals.

How do you recruit participants?

Via validated panels, employer or clinical partners, targeted social recruitment and community organisations. Recruitment strategy is tailored to ensure representation and ethical practice.

Can you work with international or cross-market studies?

Yes. We coordinate multi-country fieldwork with local partners and standardised protocols to enable cross-market comparability.

How do you protect participant privacy?

Through informed consent processes, data minimisation, encryption and strict access controls. We comply with relevant data protection laws and can align to client-specific security requirements.

What support will you provide after delivery?

We facilitate workshops to translate findings into action, support stakeholder briefings, and provide ongoing analytics on retainer if required.

Next steps — how to get started

Start with a short briefing so we can scope a tailored proposal. Please share:

Your primary objective and key decisions you must enable.
Target populations and geographies.
Timeline and budget constraints.
Any existing data or hypotheses you want us to build on.

Contact options:

Fill the contact form on this page for a prompt follow-up.
Click the WhatsApp icon to start a chat for quick clarifications.
Email us: [email protected]

We will respond with a proposed scope, timeline and budget estimate within 48 hours of receiving your brief.

Why partner with Research Bureau — evidence, ethics and impact

Choosing the right research partner matters. Working with us gives you:

Evidence-based recommendations grounded in reproducible methods and transparent assumptions.
Ethical stewardship that respects participants and protects sensitive data.
Business-focused outputs that translate research into commercial strategy.
Cross-functional collaboration—we work with product, clinical partners, legal and commercial teams to ensure recommendations are implementable.

Final note on responsibilities and limitations

Our research informs decision-making but does not replace clinical judgment or regulatory advice. We do not diagnose, treat, or provide medical recommendations. For any clinical or legal interpretation of findings, we recommend consulting licensed clinicians or legal counsel as appropriate.

Share your project details today and we’ll prepare a tailored proposal that aligns research design with your strategic priorities. Contact us via the form, WhatsApp icon, or email: [email protected]. We look forward to helping you turn evidence into impact.